Inotuzumab ozogamicin (INO) in combination with mini-hyper-CVD as frontline therapy for older patients (≥60 years) with acute lymphoblastic leukemia (ALL)
Titel:
Inotuzumab ozogamicin (INO) in combination with mini-hyper-CVD as frontline therapy for older patients (≥60 years) with acute lymphoblastic leukemia (ALL)
Auteur:
Sasaki, Koji Kantarjian, Hagop O'Brien, Susan Thomas, Deborah Garcia-Manero, Guillermo Ravandi, Farhad Dahl, Jenny Jain, Nitin Konopleva, Marina Jacob, Jovitta Garris, Rebecca Cortes, Jorge Jabbour, Elias